• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, May 25, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

CPM for knee or shoulder joints: Advantage only in two therapeutic indications

Bioengineer by Bioengineer
August 6, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Patients who have had knee or shoulder surgery or who require conservative treatment can benefit from training with motor-driven continuous passive motion (CPM) devices. However, this only applies to two therapeutic indications, and in each case only to one treatment outcome. Patients with stiff shoulder have less pain with CPM treatment than with physiotherapy alone. The range of motion after total knee replacement is improved if CPM is used in addition to physiotherapy. This is the result of the final report published by the Institute for Quality and Efficiency in Health Care (IQWiG). Hence, the conclusion was less favourable than the conclusion of the preliminary report, where the Institute had determined greater benefit of CPM also for pain in rotator cuff tear, a condition involving the rupture of tendons in the shoulder.

Early movement of joint possible

Motor-driven CPM devices allow movement of the joints without the patients needing to use their muscles. With this method, intensive activation of the joints is possible already shortly after surgery.

CPM is used to improve mobility, prevent stiffness and promote healing. It is usually not applied on its own, but as part of a multimodal therapy, supplementing physiotherapy.

Evidence base still best for total knee replacement

Compared with the preliminary report, the researchers could analyse data from two additional studies. The evidence base was still best for the use of CPM in addition to physiotherapy after total knee replacement surgery. Data of 1693 patients were available for this therapeutic indication, whereas data of fewer than 160 patients were available for each of the remaining six research questions.

Further data on rotator cuff tear: no advantage regarding pain

For rotator cuff tear, a condition involving the rupture of tendons in the shoulder requiring surgery, data from two studies with 155 participants in total were now available to the Institute for the comparison of CPM in combination with physiotherapy versus physiotherapy alone. In the preliminary report, this number was 100. Since the study additionally analysed had an opposing result for the outcome "pain", the Institute no longer sees an advantage in its final report.

Regarding the therapeutic indication of stiff shoulder, however, there is still an indication of greater benefit of CPM. The assessment in the therapeutic indication of total knee replacement also remained the same with IQWiG determining a hint of greater benefit. CPM used directly after surgery in addition to physiotherapy improves the patients' ability to move their knees.

Further studies are useful and recommended

The final report also identified evidence gaps: Usable data on health-related quality of life and adverse events are still missing. IQWiG recommends conducting further randomized controlled trials (RCTs) in the therapeutic indications where currently no (greater) benefit can be determined. In these studies, it would be important to standardize both the administration of analgesics and the respective treatment regimens of CPM and physiotherapy, and to provide detailed descriptions of their beginning and duration. Without this information, it is difficult to interpret the results.

In this final report, IQWiG assessed the benefit and harm of CPM only for knee and shoulder joints. Another completed assessment dealt with controlled active motion (CAM) devices for knees in the treatment of anterior cruciate ligament ruptures.

###

Media Contact

Anna-Sabine Ernst
[email protected]
49-221-356-850

http://www.iqwig.de/

https://www.iqwig.de/en/press/press-releases/continuous-passive-motion-for-knee-or-shoulder-joints-advantage-only-in-two-therapeutic-indications.9690.html

Share13Tweet8Share2ShareShareShare2

Related Posts

Durvalumab and Anlotinib Boost Small-Cell Lung Cancer Treatment

May 25, 2026

RBM20 Isoform Control Shapes Splicing in Health

May 24, 2026

ZNF274 Blocks Lineage Switch, Fuels CDK7 Drug Resistance

May 24, 2026

Evaluating School Policies During COVID-19 Pandemic

May 24, 2026
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    315 shares
    Share 126 Tweet 79
  • New Study Reveals Plants Can Detect the Sound of Rain

    734 shares
    Share 293 Tweet 183
  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    847 shares
    Share 339 Tweet 212
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

CBC Inflammatory Markers Forecast Risks in Elderly Diarrhea

Durvalumab and Anlotinib Boost Small-Cell Lung Cancer Treatment

Tiny Blue Octopus from the Galápagos Islands: Small Enough to Fit in the Palm of Your Hand

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.